Hologic [HOLX] vs Alcon [ALC] Detailed Stock Comparison

Hologic

NASDAQ
Loading...

Alcon

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Hologic wins in 14 metrics, Alcon wins in 5 metrics, with 0 ties. Hologic appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricHologicAlconBetter
P/E Ratio (TTM)27.8640.84Hologic
Price-to-Book Ratio3.082.07Alcon
Debt-to-Equity Ratio52.0923.63Alcon
PEG Ratio5.7826.11Hologic
EV/EBITDA12.4721.16Hologic
Profit Margin (TTM)13.79%11.28%Hologic
Operating Margin (TTM)25.48%13.30%Hologic
EBITDA Margin (TTM)25.48%13.30%Hologic
Return on Equity11.38%5.23%Hologic
Return on Assets (TTM)6.69%2.74%Hologic
Free Cash Flow (TTM)$1.15B$1.41BAlcon
1-Year Return-15.37%-22.78%Hologic
Price-to-Sales Ratio (TTM)3.704.62Hologic
Enterprise Value$15.57B$49.36BAlcon
EV/Revenue Ratio3.864.97Hologic
Gross Profit Margin (TTM)56.32%55.92%Hologic
Revenue per Share (TTM)$18$20Alcon
Earnings per Share (Diluted)$2.41$2.25Hologic
Beta (Stock Volatility)0.570.70Hologic
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Hologic vs Alcon Stock Performance Analysis

Loading Price Chart...

Hologic
Alcon
Hologic Stock Overview | Alcon Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Hologic1.30%3.22%1.95%4.00%12.14%-5.34%
Alcon0.00%2.55%-4.04%-15.89%-18.88%-9.99%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Hologic-15.37%6.51%-2.13%82.16%322.59%379.59%
Alcon-22.78%28.31%21.85%37.99%37.99%37.99%

News Based Sentiment: Hologic vs Alcon

Hologic

News based Sentiment: NEUTRAL

The month's news for Hologic paints a picture of stability rather than dramatic growth. While the stock outperformed the S&P 500 slightly and analyst estimates are trending upward, the overall sentiment is neutral due to the 'Hold' rating and modest gains. The valuation metrics suggest potential value, but don't indicate a strong buy signal.

View Hologic News Sentiment Analysis

Alcon

News based Sentiment: MIXED

Alcon's recent developments present a mixed picture. While the company exceeded earnings expectations and is pursuing a significant acquisition, lowered revenue guidance and analyst downgrades introduce uncertainty. This combination of positive and negative factors makes October a pivotal month for the company's investment narrative.

View Alcon News Sentiment Analysis

Performance & Financial Health Analysis: Hologic vs Alcon

MetricHOLXALC
Market Information
Market Cap i$14.94B$45.84B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i3,267,2601,498,680
90 Day Avg. Volume i2,018,7871,604,603
Last Close$67.91$75.11
52 Week Range$51.90 - $84.39$73.21 - $99.48
% from 52W High-19.53%-24.50%
All-Time High$87.88 (May 01, 2023)$101.10 (Sep 09, 2024)
% from All-Time High-22.72%-25.71%
Growth Metrics
Quarterly Revenue Growth0.01%0.01%
Quarterly Earnings Growth0.00%0.41%
Financial Health
Profit Margin (TTM) i0.14%0.11%
Operating Margin (TTM) i0.25%0.13%
Return on Equity (TTM) i0.11%0.05%
Debt to Equity (MRQ) i52.0923.63
Cash & Liquidity
Book Value per Share (MRQ)$21.79$44.39
Cash per Share (MRQ)$8.47$2.85
Operating Cash Flow (TTM) i$1.07B$2.12B
Levered Free Cash Flow (TTM) i$760.11M$1.18B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: Hologic vs Alcon

MetricHOLXALC
Price Ratios
P/E Ratio (TTM) i27.8640.84
Forward P/E i14.2326.11
PEG Ratio i5.7826.11
Price to Sales (TTM) i3.704.62
Price to Book (MRQ) i3.082.07
Market Capitalization
Market Capitalization i$14.94B$45.84B
Enterprise Value i$15.57B$49.36B
Enterprise Value Metrics
Enterprise to Revenue i3.864.97
Enterprise to EBITDA i12.4721.16
Risk & Other Metrics
Beta i0.570.70
Book Value per Share (MRQ) i$21.79$44.39

Financial Statements Comparison: Hologic vs Alcon

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)HOLXALC
Revenue/Sales i$1.01B$2.47B
Cost of Goods Sold i$628.00M$1.09B
Gross Profit i$377.30M$1.38B
Research & Development i$61.50M$222.00M
Operating Income (EBIT) i$37.90M$468.00M
EBITDA i$121.70M$463.00M
Pre-Tax Income i$-28.50M$414.00M
Income Tax i$-11.10M$64.00M
Net Income (Profit) i$-17.40M$350.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)HOLXALC
Cash & Equivalents i$1.43B$1.41B
Total Current Assets i$3.21B$6.07B
Total Current Liabilities i$989.70M$2.25B
Long-Term Debt i$2.47B$5.02B
Total Shareholders Equity i$4.62B$22.02B
Retained Earnings i$3.03BN/A
Property, Plant & Equipment i$939.80M$4.90B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)HOLXALC
Operating Cash Flow i$28.40MN/A
Capital Expenditures i$-24.70MN/A
Free Cash Flow i$129.20M$384.00M
Debt Repayment i$-10.20MN/A
Common Stock Repurchase i$-200.00MN/A

Short Interest & Institutional Ownership Analysis

MetricHOLXALC
Shares Short i3.11M6.89M
Short Ratio i2.034.54
Short % of Float i0.02%N/A
Average Daily Volume (10 Day) i3,267,2601,498,680
Average Daily Volume (90 Day) i2,018,7871,604,603
Shares Outstanding i231.73M494.62M
Float Shares i220.32M494.60M
% Held by Insiders i0.01%0.00%
% Held by Institutions i1.01%0.69%

Dividend Analysis & Yield Comparison: Hologic vs Alcon

MetricHOLXALC
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$0.17
3-Year Avg Dividend Yield iN/A0.30%
3-Year Total Dividends iN/A$0.50
Ex-Dividend DateN/AMay 14, 2024